Enhanced Analgesics

Over a billion people worldwide suffer from chronic pain. Opiates, often the primary treatment due to limited alternatives, have contributed to the opioid crisis because of their risks of addiction and overdose.  
 
Enhanced Analgesics has developed a non-opioid drug that is safe, highly effective and long-lasting, providing 24-48 hours of pain relief per dose. This innovation targets the $70 billion pain drug market and offers individuals suffering from chronic pain the opportunity to regain their normal lives. 

Interested in connecting? Ask the ON team via ON@csiro.au to facilitate a connection with us.

Meet the team